Squarepoint
RXST icon

Squarepoint’s RxSight RXST Stock Holding History

Squarepoint’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$193K Buy
31,318
+1,007
+3% +$8.36K ﹤0.01% 3968
2025
Q4 		$316K Sell
30,311
-60,272
-67% -$605K ﹤0.01% 3564
2025
Q3 		$814K Sell
90,583
-284,080
-76% -$2.49M ﹤0.01% 2858
2025
Q2 		$4.87M Buy
374,663
+217,608
+139% +$3.27M 0.01% 1489
2025
Q1 		$3.97M Buy
157,055
+23,930
+18% +$711K ﹤0.01% 1586
2024
Q4 		$4.58M Buy
133,125
+14,799
+13% +$667K ﹤0.01% 1714
2024
Q3 		$5.85M Buy
118,326
+20,286
+21% +$1.04M 0.01% 1307
2024
Q2 		$5.9M Sell
98,040
-11,447
-10% -$654K 0.01% 1263
2024
Q1 		$5.65M Buy
109,487
+27,504
+34% +$1.35M 0.01% 1360
2023
Q4 		$3.31M Buy
81,983
+59,123
+259% +$1.73M 0.01% 1656
2023
Q3 		$638K Buy
+22,860
New +$682K ﹤0.01% 2612

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Squarepoint's RXST Position: Q1 2026 in Review

Squarepoint increased its RxSight (RXST) stake by 3.3% in Q1 2026, buying an estimated $8.36K and bringing the position to 31,318 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #3968.

Squarepoint first reported a position in RXST in Q3 2023 and has held it in 11 quarters since. The position peaked at $5.9M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Squarepoint held 31,318 shares of RxSight worth $193K as of Q1 2026.
  • Squarepoint bought 1,007 RxSight shares in Q1 2026, an estimated $8.36K.
  • RxSight made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3968 holding.
  • Squarepoint first reported a position in RxSight in Q3 2023 and has held it in 11 quarters since.
  • Squarepoint's RxSight position peaked at $5.9M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.